Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
about
Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasmaCross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mLPotential influence of more-sensitive HIV-1 load detection by the new Roche Cobas AmpliPrep/Cobas TaqMan version 2.0 assay on clinical management of HIV-positive pregnant womenAmerican ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay.Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland.Systematic review of the performance of HIV viral load technologies on plasma samples.Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical TrialsComparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping.Evaluation of the Aptima HIV-1 Quant Dx Assay Using Plasma and Dried Blood SpotsModification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.HIV-1 load comparison using four commercial real-time assaysComparing HIV viral load assays and frequency of low level virological rebound in clinical practice.Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
P2860
Q34089637-4F9A6DB4-17D7-45A1-BF94-4D0215230596Q34301929-D4F3CE2E-F661-48B1-9704-29CEF85603BAQ34482990-3239F79A-9FF1-44B2-A3F2-F462821B45A4Q34489603-C29F1468-BC12-438C-AC83-AA2BD98E3649Q34504859-2D49EC98-3258-4B19-AEDD-8C6F2266FA2DQ35093899-26530357-69D5-4181-BB82-F5EE50E8E193Q35099443-FFF60483-E903-4425-95E8-9E3B32D2E53EQ35112701-93F694A2-62F9-4DC5-8264-1C996A79613DQ35868687-F6A87326-A612-4211-8DD1-E24A6624A7B3Q36884491-C7EE3B42-3B6D-43AC-A781-90043B696527Q37221125-2DD33D50-2E88-4553-A4EF-787108A13F48Q37264228-E4E40D57-1F62-485A-AC98-B07FC900A592Q37280615-38851514-0B1E-4DAA-84F5-4FF57AE745D7Q37308125-56FC7377-F785-4318-AC2F-E85F6752BC8CQ38088726-83A7FB0F-2D58-4183-8915-37FE3AFBAE63Q39278519-DD6FCE58-12C4-4990-8C88-EA402EBF88DBQ42113208-A2B916A0-399A-4188-AA9A-6A67138E84CAQ42230298-8316DF6E-1713-437F-9081-C8D50261A9BDQ45364475-D5F6F820-14AC-4313-8A77-E0FAB0290B0D
P2860
Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@ast
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@en
type
label
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@ast
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@en
prefLabel
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@ast
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@en
P2093
P2860
P356
P1476
Performance evaluation of the ...... nodeficiency virus type 1 RNA.
@en
P2093
Annika Pettersson
Daniel Schoener
Diana Thamke
John W A Rossen
Martin Schutten
Reiner Babiel
P2860
P304
P356
10.1128/JCM.01832-09
P407
P577
2010-02-17T00:00:00Z